AU1474601A - Protease inhibitors - Google Patents

Protease inhibitors

Info

Publication number
AU1474601A
AU1474601A AU14746/01A AU1474601A AU1474601A AU 1474601 A AU1474601 A AU 1474601A AU 14746/01 A AU14746/01 A AU 14746/01A AU 1474601 A AU1474601 A AU 1474601A AU 1474601 A AU1474601 A AU 1474601A
Authority
AU
Australia
Prior art keywords
protease inhibitors
protease
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14746/01A
Inventor
Robert W. Marquis Jr.
Yu Ru
Daniel Frank Veber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU1474601A publication Critical patent/AU1474601A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU14746/01A 1999-11-10 2000-11-08 Protease inhibitors Abandoned AU1474601A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16480099P 1999-11-10 1999-11-10
US60164800 1999-11-10
PCT/US2000/030681 WO2001034155A1 (en) 1999-11-10 2000-11-08 Protease inhibitors

Publications (1)

Publication Number Publication Date
AU1474601A true AU1474601A (en) 2001-06-06

Family

ID=22596147

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14746/01A Abandoned AU1474601A (en) 1999-11-10 2000-11-08 Protease inhibitors

Country Status (4)

Country Link
EP (1) EP1233771A4 (en)
JP (1) JP2003513923A (en)
AU (1) AU1474601A (en)
WO (1) WO2001034155A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
PL350132A1 (en) * 1998-12-23 2002-11-04 Smithkline Beecham Corp Protease inhibitors
EP1229914A4 (en) 1999-11-10 2004-06-23 Smithkline Beecham Corp Protease inhibitors
US6596715B1 (en) 1999-11-10 2003-07-22 Smithkline Beecham Corporation Protease inhibitors
EP1232154A4 (en) 1999-11-10 2004-06-23 Smithkline Beecham Corp Protease inhibitors
JP2003527429A (en) 2000-03-21 2003-09-16 スミスクライン・ビーチャム・コーポレイション Protease inhibitor
CO5280093A1 (en) * 2000-04-18 2003-05-30 Smithkline Beecham Corp TREATMENT METHODS
AU2001286983A1 (en) * 2000-09-01 2002-03-13 Smith Kline Beecham Corporation Method of treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ2285A1 (en) * 1996-08-08 2002-12-25 Smithkline Beecham Corp Cysteine protease inhibitors.
PL350132A1 (en) * 1998-12-23 2002-11-04 Smithkline Beecham Corp Protease inhibitors

Also Published As

Publication number Publication date
JP2003513923A (en) 2003-04-15
EP1233771A1 (en) 2002-08-28
WO2001034155A1 (en) 2001-05-17
EP1233771A4 (en) 2003-05-14

Similar Documents

Publication Publication Date Title
AU2001258771A1 (en) -secretase inhibitors
AU6007200A (en) Cysteine protease inhibitors
AU4723799A (en) Protease inhibitors
AU3074500A (en) Proteasome inhibitors
AU2001285750A1 (en) Urokinase inhibitors
AU2001247589A1 (en) Non-amidine containing protease inhibitors
AU7139598A (en) Protease inhibitors
AU4433700A (en) Prolyl endopeptidase inhibitor
AU4092799A (en) Protease inhibitors
AU1393900A (en) Morpholino-ethoxybenzofuran protease inhibitors
AU9110298A (en) Protease inhibitors
EP1235577A4 (en) Protease inhibitors
AU7126900A (en) Enzyme inhibitors
AU1588901A (en) Protease inhibitors
AU3235100A (en) Prothease inhibitors
AU1474801A (en) Protease inhibitors
AU2713100A (en) Protease inhibitors
AU4564499A (en) Protease inhibitors
EP1231921A4 (en) Protease inhibitors
EP1229912A4 (en) Protease inhibitors
EP1229915A4 (en) Protease inhibitors
AU4066900A (en) Protease inhibitors
AU1474601A (en) Protease inhibitors
AU3888200A (en) Protease inhibitors
AU1474701A (en) Protease inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase